Latest Breaking News On - Fahar merchant - Page 6 : comparemela.com

Medicenna Reports First Quarter Fiscal 2024 Financial Results and Operational Highlights

Medicenna Reports First Quarter Fiscal 2024 Financial Results and Operational Highlights
financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkKevin carmichaelJake edmistonGabriel friedmanSuperkine immunotherapiesNational postNational brain tumor societyPostmedia network incSafety review committeeMedicenna therapeutics corpResearch roundtableMedicenna reports first quarter fiscalOperational highlightsReview committeeVictoria wells

Medicenna Reports Fiscal Year 2023 Financial Results and Operational Highlights

Medicenna Reports Fiscal Year 2023 Financial Results and Operational Highlights
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSuperkine immunotherapiesTony russoElizabeth williamsSuperkine programTrademark officeMedicenna therapeutics corpMeeting of the international cytokine interferon societySociety for immunotherapy of cancerOppenheimer coDrug administrationReports fiscal yearFahar merchantUnited states patentAmerican associationAnnual meeting

Letko Brosseau & Associates Inc Grows Stock Holdings in Medicenna Therapeutics Corp (NASDAQ:MDNA)

Letko Brosseau & Associates Inc. increased its stake in shares of Medicenna Therapeutics Corp. (NASDAQ:MDNA – Get Rating) by 70.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 170,000 shares of the company’s stock after buying an additional 70,000 shares during […]

Annandale capitalLetko brosseau associates incRathbones group plcSigma planning corpMedicenna therapeutics corpMaven securitiesSecurities exchange commissionLetko brosseauMedicenna therapeuticsGet ratingGroup plcPlanning corpEmpowered cytokinesFahar merchantRosemina merchantVisit holdingschannel

Medicenna Therapeutics (NASDAQ:MDNA) Trading Down 1 8%

Medicenna Therapeutics Corp. (NASDAQ:MDNA – Get Rating)’s stock price dropped 1.8% during mid-day trading on Thursday . The stock traded as low as $0.74 and last traded at $0.74. Approximately 70,588 shares were traded during mid-day trading, a decline of 30% from the average daily volume of 100,742 shares. The stock had previously closed at […]

Rathbones group plcAnnandale capitalLetko brosseau associates incRenaissance technologiesMedicenna therapeutics corpMillennium managementMedicenna therapeuticsGet ratingTherapeutics trading downGroup plcEmpowered cytokinesFahar merchantRosemina merchantMedicenna therapeutics dailyNasdaq mdna

Medicenna Therapeutics (NASDAQ:MDNA) Trading Down 1 8%

Medicenna Therapeutics Corp. (NASDAQ:MDNA – Get Rating) was down 1.8% on Thursday . The company traded as low as $0.74 and last traded at $0.74. Approximately 70,588 shares were traded during trading, a decline of 30% from the average daily volume of 100,742 shares. The stock had previously closed at $0.76. Analyst Ratings Changes Separately, […]

Medicenna therapeutics corpMillennium managementLetko brosseau associates incRenaissance technologiesCapital managementSigma planning corpMedicenna therapeutics company profileMedicenna therapeuticsGet ratingTherapeutics stock downPlanning corpEmpowered cytokinesFahar merchantRosemina merchantMedicenna therapeutics dailyNasdaq mdna